Jiang-Jiang Qin (Jiangjiang Qin)

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 14

Top Venues

Nature communications

PNAS nexus

Molecular cancer

Oncogene

Institute of Cancer and Basic Medicine, Chinese Academy of Sciences

Shanghai Jiao Tong University, School of Pharmacy (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Cancer and Basic Medicine, Chinese Academy of Sciences Sep 1o 2020

China

Professor, Principle Investigator

Education History

Shanghai Jiao Tong University, School of Pharmacy Sep 1o 2006 - May 25o 2011

China

PHD

Publications

Shengli Li, Li Yuan, Zhi-Yuan Xu, Jing-Li Xu, Gui-Ping Chen, Xiaoqing Guan, Guang-Zhao Pan, Can Hu, Jinyun Dong, Yi-An Du, Li-Tao Yang, Mao-Wei Ni, Rui-Bin Jiang, Xiu Zhu, Hang Lv, Han-Dong Xu, Sheng-Jie Zhang, Jiang-Jiang Qin, Xiang-Dong Cheng
Integrative proteomic characterization of adenocarcinoma of esophagogastric junction. Nature communications 14 (1) (2023)
Shengli Li, Li Yuan, Zhi-Yuan Xu, Jing-Li Xu, Gui-Ping Chen, Xiaoqing Guan, Guang-Zhao Pan, Can Hu, Jinyun Dong, Yi-An Du, Li-Tao Yang, Mao-Wei Ni, Rui-Bin Jiang, Xiu Zhu, Hang Lv, Han-Dong Xu, Sheng-Jie Zhang, Jiang-Jiang Qin, Xiang-Dong Cheng
Integrative proteomic characterization of adenocarcinoma of esophagogastric junction. Nature communications 14 (1) (2023)
Handong Xu, Can Hu, Yi Wang, Yunfu Shi, Li Yuan, Jingli Xu, Yanqiang Zhang, Jiahui Chen, Qin Wei, Jiang-Jiang Qin, Zhiyuan Xu, Xiangdong Cheng
Glutathione peroxidase 2 knockdown suppresses gastric cancer progression and metastasis via regulation of kynurenine metabolism. Oncogene (2023)
Shengli Li, Li Yuan, Zhi-Yuan Xu, Jing-Li Xu, Gui-Ping Chen, Xiaoqing Guan, Guang-Zhao Pan, Can Hu, Jinyun Dong, Yi-An Du, Li-Tao Yang, Mao-Wei Ni, Rui-Bin Jiang, Xiu Zhu, Hang Lv, Han-Dong Xu, Sheng-Jie Zhang, Jiang-Jiang Qin, Xiang-Dong Cheng
Integrative proteomic characterization of adenocarcinoma of esophagogastric junction. Nature communications 14 (1) (2023)
Shengli Li, Li Yuan, Zhi-Yuan Xu, Jing-Li Xu, Gui-Ping Chen, Xiaoqing Guan, Guang-Zhao Pan, Can Hu, Jinyun Dong, Yi-An Du, Li-Tao Yang, Mao-Wei Ni, Rui-Bin Jiang, Xiu Zhu, Hang Lv, Han-Dong Xu, Sheng-Jie Zhang, Jiang-Jiang Qin, Xiang-Dong Cheng
Integrative proteomic characterization of adenocarcinoma of esophagogastric junction. Nature communications 14 (1) (2023)
Wei-Hui Zheng, Chun Liu, Jiaoyue Jin, Wei Sun, Jianqiang Zhao, Ming Zhao, Shili Yao, Bing Zhu, Fan Chen, Jinbiao Shang, Kejing Wang, Peng Guo, Jiang-Jiang Qin, Xiangdong Cheng
Biodegradable iron oxide nanoparticles for intraoperative parathyroid gland imaging in thyroidectomy. PNAS nexus 1 (3) (2022)
Simin Qi, Xiaoqing Guan, Jia Zhang, Dehua Yu, Xuefei Yu, Qinglin Li, Wenjuan Yin, Xiang-Dong Cheng, Weidong Zhang, Jiang-Jiang Qin
Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and metastasis. Molecular cancer 21 (1) (2022)
Wei-Hui Zheng, Chun Liu, Jiaoyue Jin, Wei Sun, Jianqiang Zhao, Ming Zhao, Shili Yao, Bing Zhu, Fan Chen, Jinbiao Shang, Kejing Wang, Peng Guo, Jiang-Jiang Qin, Xiangdong Cheng
Biodegradable iron oxide nanoparticles for intraoperative parathyroid gland imaging in thyroidectomy. PNAS nexus 1 (3) (2022)
Dehua Yu, Zhiyuan Xu, Xiangdong Cheng, Jiang-Jiang Qin
The role of miRNAs in MDMX-p53 interplay. Journal of evidence-based medicine 14 (2) (2021)
Jinyun Dong, Xiang-Dong Cheng, Wei-Dong Zhang, Jiang-Jiang Qin
Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation. Journal of medicinal chemistry 64 (13) (2021)
Haobin Li, Jinyun Dong, Maohua Cai, Zhiyuan Xu, Xiang-Dong Cheng, Jiang-Jiang Qin
Protein degradation technology: a strategic paradigm shift in drug discovery. Journal of hematology & oncology 14 (1) (2021)
Li Yuan, Zhi-Yuan Xu, Shan-Ming Ruan, Shaowei Mo, Jiang-Jiang Qin, Xiang-Dong Cheng
Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance. Molecular cancer 19 (1) (2020)
Jiang-Jiang Qin, Xiang-Dong Cheng, Jia Zhang, Wei-Dong Zhang
Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review. Cell communication and signaling : CCS 17 (1) (2019)
Jiang-Jiang Qin, Li Yan, Jia Zhang, Wei-Dong Zhang
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review. Journal of experimental & clinical cancer research : CR 38 (1) (2019)

Jiang-Jiang Qin.css-eqlu8i{font-size:small;padding-left:4px;} (Jiangjiang Qin)

Publication Activity (10 Years)

Top Topics

Top Venues

Jiang-Jiang Qin (Jiangjiang Qin)